Diabetes, Obesity and Metabolism

β-Cell mass plasticity in type 2 diabetes
pp. 319-331(13)
Authors: Prato, S. Del; Wishner, W. J.; Gromada, J.; Schluchter, B. J.

Changes in serum leptin concentrations in overweight Japanese men after exercise
pp. 332-337(6)
Authors: Miyatake, N.; Takahashi, K.; Wada, J.; Nishikawa, H.; Morishita, A.; Suzuki, H.; Kunitomi, M.; Makino, H.; Kira, S.; Fujii, M.

Lipids and lipoprotein(a) concentrations in Pakistani patients with type 2 diabetes mellitus
pp. 338-343(6)
Authors: Habib, S. S.; Aslam, M.

Nateglinide alone or with metformin safely improves glycaemia to target in patients up to an age of 84
pp. 344-352(9)
Authors: Weaver, J. U.; Robertson, D.; Atkin, S. L.

Characteristics of US adults with the metabolic syndrome and therapeutic implications
pp. 353-362(10)
Authors: Jacobson, T. A.; Case, C. C.; Roberts, S.; Buckley, A.; Murtaugh, K. M.; Sung, J. C. Y.; Gause, D.; Varas, C.; Ballantyne, C. M.

Outcomes of initiation of therapy with once-daily combination of a thiazolidinedione and a biguanide at an early stage of type 2 diabetes
pp. 363-366(4)
Authors: Bell, D. S. H.; Ovalle, F.

Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community
pp. 367-374(8)
Authors: Östgren, C. J.; Merlo, J.; Råstam, L.; Lindblad, U.

Effects of orlistat on obesity-related diseases - a six-month randomized trial
pp. 375-383(9)
Authors: Guy-Grand, B.; Drouin, P.; Eschwège, E.; Gin, H.; Joubert, J-M.; Valensi, P.

Acarbose lowers serum triglyceride and postprandial chylomicron levels in type 2 diabetes
pp. 384-390(7)
Authors: Ogawa, S.; Takeuchi, K.; Ito, S.

The diagnostic value of determining the hydroxy metabolite of glimepiride (M1) in blood serum in cases of severe hypoglycaemia associated with glimepiride therapy
pp. 391-393(3)
Authors: Holstein, A.; Plaschke, A.; Ptak, M.; Egberts, E.-H.; Tenberken, O.; Maurer, H. H.

News and Views
pp. 394-398(5)
Author: Holt, Richard I. G.